Clinical validation of next-generation sequencing-based clonality assays for minimal residual disease tracking in multiple myeloma

被引：0
|
作者：
Lin, Chuanming
Jian, Qijie
Huang, Zoufang
Xie, Shuiling
Xin, Liuyan
Wu, Haiyan
Pang, Fei
Liao, Changfeng
Chen, Yijian
机构：
[1] Gannan Med Univ, Affiliated Hosp 1, Ganzhou, Peoples R China
[2] Shanghai OrigiMed Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20037
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Validation of Next Generation Sequencing-Based Clonality Assays for Diagnosis and Minimal Residual Disease Tracking in Lymphoid Malignancies
    Wu, Haiyan
    Li, Feng
    Cai, Jiacheng
    Zhang, Ke
    Zheng, Xin
    Yao, Jicheng
    Wang, Weifeng
    Wang, Kai
    BLOOD, 2021, 138
  • [2] Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
    Yao, Qiumei
    Bai, Yinlei
    Orfao, Alberto
    Chim, Chor Sang
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [3] Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
    Yao, Qiumei
    Bai, Yinlei
    Orfao, Alberto
    Kumar, Shaji
    Chim, Chor S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : 679 - 684
  • [4] Clinical Utility of Next-Generation Sequencing-Based Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
    Sekiya, Yuko
    Okuno, Yusuke
    Muramatsu, Hideki
    Narita, Atsushi
    Suzuki, Kyogo
    Wang, Xinan
    Kawashima, Nozomu
    Xu, Yinyan
    Sakaguchi, Hirotoshi
    Yoshida, Nao
    Hama, Asahito
    Takahashi, Yoshiyuki
    Kato, Koji
    Kojima, Seiji
    BLOOD, 2015, 126 (23)
  • [5] Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia
    Mai, Huirong
    Li, Qin
    Wang, Guobing
    Wang, Ying
    Liu, Shilin
    Tang, Xue
    Chen, Fen
    Zhou, Guichi
    Liu, Yi
    Li, Tonghui
    Wang, Lulu
    Wang, Chunyan
    Wen, Feiqiu
    Liu, Sixi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3259 - 3266
  • [6] Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia
    Huirong Mai
    Qin Li
    Guobing Wang
    Ying Wang
    Shilin Liu
    Xue Tang
    Fen Chen
    Guichi Zhou
    Yi Liu
    Tonghui Li
    Lulu Wang
    Chunyan Wang
    Feiqiu Wen
    Sixi Liu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3259 - 3266
  • [7] Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma
    Medina, Alejandro
    Jimenez, Cristina
    Puig, Noemi
    Sarasquete, Maria Eugenia
    Flores-Montero, Juan
    Garcia-Alvarez, Maria
    Prieto-Conde, Isabel
    Chillon, Carmen
    Alcoceba, Miguel
    Gonzalez-Calle, Veronica
    Gutierrez, Norma C.
    Jacobsen, Austin
    Vigil, Edgar
    Hutt, Kasey
    Huang, Ying
    Orfao, Alberto
    Gonzalez, Marcos
    Miller, Jeffrey
    Garcia-Sanz, Ramon
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (07) : 862 - 871
  • [8] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
    Alejandro Medina
    Noemi Puig
    Juan Flores-Montero
    Cristina Jimenez
    M.-Eugenia Sarasquete
    María Garcia-Alvarez
    Isabel Prieto-Conde
    Carmen Chillon
    Miguel Alcoceba
    Norma C. Gutierrez
    Albert Oriol
    Laura Rosinol
    Joan Bladè
    Mercedes Gironella
    Miguel T. Hernandez
    Veronica Gonzalez-Calle
    Maria-Teresa Cedena
    Bruno Paiva
    Jesus F. San-Miguel
    Juan-Jose Lahuerta
    Maria-Victoria Mateos
    Joaquin Martinez-Lopez
    Alberto Orfao
    Marcos Gonzalez
    Ramon Garcia-Sanz
    Blood Cancer Journal, 10
  • [9] Comparison of Next-Generation Flow Cytometry (NGF) and Next-Generation Sequencing (NGS) in the Assessment of Minimal Residual Disease in Multiple Myeloma
    Wang, Qingqing
    Yao, Li
    Zhu, Mingqing
    Yan, Lingzhi
    Jin, Song
    Shang, Jingjing
    Shi, Xiaolan
    Zhai, Yingying
    Yan, Shuang
    Yao, Weiqin
    You Hongying
    Wu, Depei
    Fu, Chengcheng
    BLOOD, 2022, 140 : 7249 - 7250
  • [10] Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
    Medina, Alejandro
    Puig, Noemi
    Flores-Montero, Juan
    Jimenez, Cristina
    Sarasquete, M. -Eugenia
    Garcia-Alvarez, Maria
    Prieto-Conde, Isabel
    Chillon, Carmen
    Alcoceba, Miguel
    Gutierrez, Norma C.
    Oriol, Albert
    Rosinol, Laura
    Blade, Joan
    Gironella, Mercedes
    Hernandez, Miguel T.
    Gonzalez-Calle, Veronica
    Cedena, Maria-Teresa
    Paiva, Bruno
    San-Miguel, Jesus F.
    Lahuerta, Juan-Jose
    Mateos, Maria-Victoria
    Martinez-Lopez, Joaquin
    Orfao, Alberto
    Gonzalez, Marcos
    Garcia-Sanz, Ramon
    BLOOD CANCER JOURNAL, 2020, 10 (10)
12345